
Irish Times
<img alt="" height="1" width="1" />
Ahead of the Bell: Blood thinner study impresses
BusinessWeek
The blood thinner from Pfizer and Bristol-Myers demonstrated an impressive reduction in major bleeding in clinical trials and could emerge as the leading brand in stroke prevention, according to a Jefferies analyst. Eliquis was approved in the European ...
Study Gives Lift to Drug That Cuts Stroke RiskWall Street Journal
Pfizer, Bristol-Myers Blood Thinner Eliquis Cut Deaths in StudyBloomberg
Trial Shows Blockbuster Potential for Blood Clot PillNew York Times
WebMD -U.S. News & World Report -CBS News
all 127 news articles »
More...